Boston Scientific expects headcount reductions amid restructuring initiative
Boston expects its restructuring plan to cost between $700m and $800m and be completed by the end of 2029.
Boston expects its restructuring plan to cost between $700m and $800m and be completed by the end of 2029.
The National Healthtech Access Programme aims to improve accessibility to healthtech products across the NHS.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Intuitive Surgical expands platforms despite market headwind
The increased importance of safety for wearable devices
What does the EU Data Act mean for businesses?
GE HealthCare launches new ultrasound system for cardiovascular imaging